Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1262) 1262
pulse therapy, drug (915) 915
female (816) 816
methylprednisolone - administration & dosage (816) 816
science & technology (810) 810
life sciences & biomedicine (807) 807
male (786) 786
treatment outcome (551) 551
adult (542) 542
middle aged (487) 487
glucocorticoids - administration & dosage (278) 278
biological and medical sciences (259) 259
medical sciences (259) 259
aged (256) 256
drug therapy, combination (251) 251
methylprednisolone - therapeutic use (244) 244
adolescent (224) 224
methylprednisolone (218) 218
prednisolone - administration & dosage (206) 206
child (193) 193
immunosuppressive agents - administration & dosage (186) 186
cyclophosphamide - administration & dosage (176) 176
rheumatology (171) 171
magnetic resonance imaging (161) 161
corticosteroids (155) 155
retrospective studies (155) 155
anti-inflammatory agents - administration & dosage (153) 153
medicine & public health (145) 145
methylprednisolone - adverse effects (137) 137
infusions, intravenous (135) 135
urology & nephrology (135) 135
administration, oral (130) 130
glucocorticoids - therapeutic use (127) 127
pulse therapy (125) 125
time factors (124) 124
follow-up studies (120) 120
pediatrics (119) 119
steroid pulse therapy (119) 119
care and treatment (113) 113
child, preschool (112) 112
immunosuppressive agents - therapeutic use (109) 109
injections, intravenous (109) 109
general & internal medicine (106) 106
severity of illness index (105) 105
dermatology (104) 104
methylprednisolone pulse therapy (101) 101
medicine, general & internal (100) 100
recurrence (100) 100
young adult (96) 96
ophthalmology (94) 94
pharmacology. drug treatments (94) 94
systemic lupus erythematosus (91) 91
biopsy (89) 89
drug administration schedule (89) 89
cyclophosphamide (88) 88
acute disease (87) 87
anti-inflammatory agents - therapeutic use (81) 81
prospective studies (77) 77
remission induction (77) 77
neurosciences & neurology (75) 75
biomarkers - blood (74) 74
combined modality therapy (74) 74
cyclophosphamide - therapeutic use (72) 72
diagnosis, differential (72) 72
drug therapy (70) 70
dose-response relationship, drug (69) 69
lupus erythematosus, systemic - drug therapy (69) 69
prognosis (69) 69
abridged index medicus (68) 68
patients (66) 66
lupus erythematosus, systemic - complications (65) 65
steroids (65) 65
clinical neurology (64) 64
glucocorticoids - adverse effects (64) 64
plasma exchange (64) 64
risk factors (63) 63
disease progression (60) 60
infant (58) 58
case report (54) 54
aged, 80 and over (53) 53
prednisolone - therapeutic use (52) 52
tomography, x-ray computed (52) 52
children (51) 51
tonsillectomy (51) 51
kidney - pathology (50) 50
autoantibodies - blood (47) 47
glomerulonephritis (47) 47
surgery (47) 47
dosage and administration (46) 46
iga nephropathy (46) 46
immunosuppressive agents - adverse effects (46) 46
pulse therapy, drug - methods (46) 46
anti-inflammatory agents - adverse effects (45) 45
health aspects (45) 45
lupus nephritis - drug therapy (45) 45
prednisolone (45) 45
drug resistance (44) 44
lupus (44) 44
nephrology (44) 44
glomerulonephritis, iga - drug therapy (43) 43
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1235) 1235
Japanese (379) 379
French (15) 15
Russian (13) 13
Korean (9) 9
German (8) 8
Spanish (7) 7
Polish (6) 6
Portuguese (6) 6
Chinese (5) 5
Hungarian (2) 2
Italian (2) 2
Czech (1) 1
Dutch (1) 1
Indonesian (1) 1
Persian (1) 1
Romanian (1) 1
Swedish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Meta‐analysis of methylprednisolone pulse therapy for Graves' ophthalmopathy
by Gao, Guohong and Dai, Jinhui and Qian, Yifeng and Ma, Fei
Clinical & experimental ophthalmology, ISSN 1442-6404, 11/2014, Volume 42, Issue 8, pp. 769 - 777
glucocorticoid | drug therapy | Graves' ophthalmopathy | meta‐analysis | Drug therapy | Glucocorticoid | Meta-analysis | Life Sciences & Biomedicine | Ophthalmology | Science & Technology | Glucocorticoids - administration & dosage | Administration, Oral | Humans | Combined Modality Therapy | Infusions, Intravenous | Graves Ophthalmopathy - drug therapy | Pulse Therapy, Drug | Radiotherapy | Methylprednisolone - administration & dosage | Corticosteroids | Methylprednisolone | Analysis | Weapons of mass destruction | Confidence intervals | Medical research | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Monthly oral methylprednisolone pulse treatment in progressive multiple sclerosis
by Ratzer, Rikke and Iversen, Pernille and Börnsen, Lars and Dyrby, Tim B and Romme Christensen, Jeppe and Ammitzbøll, Cecilie and Madsen, Camilla Gøbel and Garde, Ellen and Lyksborg, Mark and Andersen, Birgit and Hyldstrup, Lars and Sørensen, Per Soelberg and Siebner, Hartwig R and Sellebjerg, Finn
Multiple sclerosis, ISSN 1352-4585, 6/2016, Volume 22, Issue 7, pp. 926 - 934
clinical trial | Progressive multiple sclerosis | methylprednisolone | magnetization transfer ratio | osteopontin | cerebrospinal fluid | Neurosciences | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Predictive Value of Tests | Recurrence | Glucocorticoids - administration & dosage | Humans | Middle Aged | Male | Methylprednisolone - adverse effects | Multiple Sclerosis, Chronic Progressive - diagnostic imaging | Recovery of Function | Young Adult | Evoked Potentials, Motor | Inflammation Mediators - cerebrospinal fluid | Time Factors | Adult | Female | Multiple Sclerosis, Chronic Progressive - drug therapy | Glucocorticoids - adverse effects | Multiple Sclerosis, Chronic Progressive - cerebrospinal fluid | Multiple Sclerosis, Chronic Progressive - physiopathology | Bone Density | Administration, Oral | Osteopontin - cerebrospinal fluid | Treatment Outcome | Pulse Therapy, Drug | Disease Progression | Diffusion Tensor Imaging | Magnetic Resonance Imaging | Neurologic Examination | Adolescent | Denmark | Aged | Biomarkers - cerebrospinal fluid | Methylprednisolone - administration & dosage | Multiple sclerosis | Nuclear magnetic resonance--NMR | Osteopontin | Cerebrospinal fluid | Motor evoked potentials | Motor task performance | Methylprednisolone | Side effects | Magnetic resonance imaging | Demyelination | Evoked potentials | Bone density | Bone imaging | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients
by Soo, Y.O.Y and Cheng, Y and Wong, R and Hui, D.S and Lee, C.K and Tsang, K.K.S and Ng, M.H.L and Chan, P and Cheng, G and Sung, J.J.Y
Clinical microbiology and infection, ISSN 1198-743X, 07/2004, Volume 10, Issue 7, pp. 676 - 678
methylprednisolone | treatment | SARS | Convalescent plasma | ribavarin | severe acute respiratory syndrome | Ribavarin | Treatment | Methylprednisolone | Severe acute respiratory syndrome | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Biological and medical sciences | Viral diseases of the respiratory system and ent viral diseases | Infectious diseases | Medical sciences | Human viral diseases | Viral diseases | Methylprednisolone - therapeutic use | Antiviral Agents - therapeutic use | Humans | Middle Aged | Ribavirin - therapeutic use | Plasma - immunology | Severe Acute Respiratory Syndrome - immunology | SARS Virus - drug effects | Severe Acute Respiratory Syndrome - mortality | Male | Treatment Outcome | Pulse Therapy, Drug | Severe Acute Respiratory Syndrome - drug therapy | Antiviral Agents - administration & dosage | Convalescence | Ribavirin - administration & dosage | Anti-Inflammatory Agents - therapeutic use | Adult | Anti-Inflammatory Agents - administration & dosage | Female | Aged | Retrospective Studies | Drug Therapy, Combination | Methylprednisolone - administration & dosage | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Blood pressure profile and N-terminal-proBNP dynamics in response to intravenous methylprednisolone pulse therapy of severe graves’ orbitopathy
by Miskiewicz, Piotr and Milczarek-Banach, Justyna and Bednarczuk, Tomasz and Opolski, Grzegorz and Glowczynska, Renata
International journal of molecular sciences, ISSN 1661-6596, 10/2018, Volume 19, Issue 10, p. 2918
Hypertension | Pulse therapy | NT-proBNP | Glucocorticoids | Graves’ disease | Blood pressure | Methylprednisolone | Graves’ orbitopathy | Ambulatory blood pressure monitoring | Biochemistry & Molecular Biology | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Chemistry, Multidisciplinary | Science & Technology | Severity of Illness Index | Glucocorticoids - administration & dosage | Glucocorticoids - therapeutic use | Natriuretic Peptide, Brain - analysis | Prospective Studies | Methylprednisolone - therapeutic use | Humans | Middle Aged | Male | Pulse Therapy, Drug | Peptide Fragments - analysis | Adult | Female | Blood Pressure - drug effects | Graves Ophthalmopathy - pathology | Infusions, Intravenous | Blood Pressure Monitoring, Ambulatory | Graves Ophthalmopathy - drug therapy | Methylprednisolone - administration & dosage | Index Medicus | ambulatory blood pressure monitoring | blood pressure | pulse therapy | methylprednisolone | glucocorticoids | graves’ orbitopathy | hypertension
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Methylprednisolone pulse therapy for refractory Mycoplasma pneumoniae pneumonia in children
by Tamura, Akihiro and Matsubara, Kousaku and Tanaka, Takayuki and Nigami, Hiroyuki and Yura, Kazuo and Fukaya, Takashi
The Journal of infection, ISSN 0163-4453, 2008, Volume 57, Issue 3, pp. 223 - 228
Infectious Disease | Refractory | Mycoplasma pneumoniae | Children | Methylprednisolone | Pulse | Life Sciences & Biomedicine | Infectious Diseases | Science & Technology | General aspects | Respiratory system : syndromes and miscellaneous diseases | Pharmacology. Drug treatments | Bones, joints and connective tissue. Antiinflammatory agents | Biological and medical sciences | Medical sciences | Pneumology | Mycoplasma pneumoniae - drug effects | Methylprednisolone - therapeutic use | Humans | Child, Preschool | Male | Methylprednisolone - adverse effects | Treatment Outcome | Anti-Bacterial Agents - therapeutic use | Anti-Inflammatory Agents - adverse effects | Anti-Inflammatory Agents - therapeutic use | Anti-Inflammatory Agents - administration & dosage | Female | Radiography, Thoracic | Infusions, Intravenous | Child | Methylprednisolone - administration & dosage | Pneumonia, Mycoplasma - drug therapy | Pneumonia | Care and treatment | Corticosteroids | Bacterial pneumonia | Steroids | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Methylprednisolone pulse therapy in 31 patients with refractory epilepsy: A single-center retrospective analysis
by Kimizu, Tomokazu and Takahashi, Yukitoshi and Oboshi, Taikan and Horino, Asako and Omatsu, Hirowo and Koike, Takayoshi and Yoshitomi, Shinsaku and Yamaguchi, Tokito and Otani, Hideyuki and Ikeda, Hiroko and Imai, Katsumi and Shigematsu, Hideo
Epilepsy & behavior, ISSN 1525-5050, 08/2020, Volume 109, pp. 107116 - 107116
Methylprednisolone pulse therapy | Refractory epilepsy | Corticosteroid | Cognitive deficit | Immune-mediated epilepsy | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Psychiatry | Behavioral Sciences | Science & Technology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Efficacy of intravenous methylprednisolone pulse therapy in patients with multiple sclerosis and neuromyelitis optica
by Yamasaki, Ryo and Matsushita, Takuya and Fukazawa, Toshiyuki and Yokoyama, Kazumasa and Fujihara, Kazuo and Ogino, Mieko and Yokota, Takanori and Miyamoto, Katsuichi and Niino, Masaaki and Nomura, Kyoichi and Tomioka, Ryo and Tanaka, Masami and Kawachi, Izumi and Ohashi, Takashi and Kaida, Ken-ichi and Matsui, Makoto and Nakatsuji, Yuji and Ochi, Hirofumi and Fukaura, Hikoaki and Kanda, Takashi and Nagaishi, Akiko and Togo, Kanae and Mizusawa, Hidehiro and Murai, Hiroyuki and Kira, Jun-ichi
Multiple sclerosis, ISSN 1352-4585, 9/2016, Volume 22, Issue 10, pp. 1337 - 1348
methylprednisolone | Multiple sclerosis | pulse therapy | corticosteroids | neuromyelitis optica | Neurosciences | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Glucocorticoids - administration & dosage | Neuromyelitis Optica - drug therapy | Humans | Middle Aged | Male | Treatment Outcome | Young Adult | Administration, Intravenous | Adolescent | Aged, 80 and over | Adult | Female | Aged | Retrospective Studies | Child | Methylprednisolone - administration & dosage | Multiple Sclerosis - drug therapy | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Multidimensional improvement in connective tissue disease‐associated interstitial lung disease: Two courses of pulse dose methylprednisolone followed by low‐dose prednisone and tacrolimus
by Yamano, Yasuhiko and Taniguchi, Hiroyuki and Kondoh, Yasuhiro and Ando, Masahiko and Kataoka, Kensuke and Furukawa, Taiki and Johkoh, Takeshi and Fukuoka, Junya and Sakamoto, Koji and Hasegawa, Yoshinori
Respirology (Carlton, Vic.), ISSN 1323-7799, 11/2018, Volume 23, Issue 11, pp. 1041 - 1048
collagen vascular diseases | quality of life | interstitial lung disease | autoimmune disease | respiratory function test | Life Sciences & Biomedicine | Respiratory System | Science & Technology | Lung Diseases, Interstitial - etiology | Lung - pathology | Prednisone - administration & dosage | Lung Diseases, Interstitial - pathology | Humans | Japan | Middle Aged | Respiratory Function Tests - methods | Male | Treatment Outcome | Lung - physiopathology | Lung Diseases, Interstitial - drug therapy | Drug Therapy, Combination - methods | Connective Tissue Diseases - drug therapy | Connective Tissue Diseases - pathology | Female | Aged | Retrospective Studies | Pulse Therapy, Drug - methods | Connective Tissue Diseases - complications | Immunosuppressive Agents - administration & dosage | Methylprednisolone - administration & dosage | Tacrolimus - administration & dosage | Medical research | Corticosteroids | Lung diseases | Arthritis | Pulmonary function tests | Immunosuppressive agents | Rheumatoid factor | Blood circulation disorders | Collagen | Physiological aspects | Medicine, Experimental | Dosage and administration | Steroids | Corticoids | Oxygen | Sjogren's syndrome | Intravenous administration | Dermatomyositis | Prednisone | Methylprednisolone | Patients | Tacrolimus | Rheumatoid arthritis | Carbon monoxide | Prednisolone | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Methylprednisolone-induced liver injury: A diagnostic challenge
by Melamud, Bernardo and Lurie, Yoav and Goldin, Eran and Levi, Izhar and Esayag, Yaacov
The Israel Medical Association journal, ISSN 1565-1088, 2014, Volume 16, Issue 3, pp. 180 - 181
Druginduced liver injury | Drug-induced liver injury (DILI) | Graves' ophthalmopathy | Methylprednisolone | Hepatotoxicity | Naranjo scale | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Glucocorticoids - administration & dosage | Glucocorticoids - therapeutic use | Methylprednisolone - therapeutic use | Humans | Middle Aged | Male | Methylprednisolone - adverse effects | Pulse Therapy, Drug | Chemical and Drug Induced Liver Injury - diagnosis | Administration, Intravenous | Chemical and Drug Induced Liver Injury - pathology | Graves Ophthalmopathy - drug therapy | Chemical and Drug Induced Liver Injury - etiology | Glucocorticoids - adverse effects | Methylprednisolone - administration & dosage
Journal Article
Details down arrow
10. Full Text Methylprednisolone and Hepatotoxicity in Graves' Ophthalmopathy
by Wichary, Hanna and Gasińska, Teresa
Thyroid (New York, N.Y.), ISSN 1050-7256, 01/2012, Volume 22, Issue 1, pp. 64 - 69
Immunology, Autoimmunity, and Graves' Ophthalmopathy | Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Liver Function Tests | Humans | Middle Aged | Male | Methylprednisolone - adverse effects | Liver - physiopathology | Pulse Therapy, Drug | Hepatitis B - immunology | Liver - drug effects | Female | Immunosuppressive Agents - adverse effects | Graves Ophthalmopathy - drug therapy | Immunosuppressive Agents - administration & dosage | Methylprednisolone - administration & dosage | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Liver injury after pulsed methylprednisolone therapy in multiple sclerosis patients
by Nociti, Viviana and Biolato, Marco and De Fino, Chiara and Bianco, Assunta and Losavio, Francesco Antonio and Lucchini, Matteo and Marrone, Giuseppe and Grieco, Antonio and Mirabella, Massimiliano
Brain and behavior, ISSN 2162-3279, 06/2018, Volume 8, Issue 6, pp. e00968 - n/a
liver injury | steroids | relapse | multiple sclerosis | Liver Function Tests | Severity of Illness Index | Chemical and Drug Induced Liver Injury - prevention & control | Glucocorticoids - administration & dosage | Prevalence | Prospective Studies | Humans | Middle Aged | Chemical and Drug Induced Liver Injury - epidemiology | Male | Methylprednisolone - adverse effects | Drug Monitoring - methods | Secondary Prevention - methods | Chemical and Drug Induced Liver Injury - diagnosis | Drug Monitoring - standards | Adult | Female | Italy - epidemiology | Pulse Therapy, Drug - methods | Chemical and Drug Induced Liver Injury - etiology | Glucocorticoids - adverse effects | Methylprednisolone - administration & dosage | Multiple Sclerosis - drug therapy | Evaluation | Medical research | Multiple sclerosis | Care and treatment | Corticosteroids | Liver | Medicine, Experimental | Methylprednisolone | Steroids | Bile | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text The effect of pulse methylprednisolone induction therapy in Chinese patients with dialysis-dependent MPO-ANCA associated vasculitis
by Huang, Li and Zhong, Yong and Ooi, Joshua D and Zhou, Ya-Ou and Zuo, Xiaoxia and Luo, Hui and Chen, Jin-Biao and Wu, Ting and Yang, Yingqiang and Meng, Ting and Xiao, Zhou and Lin, Wei and Ao, Xiang and Xiao, Xiangcheng and Zhou, Qiaoling and Xiao, Ping
International immunopharmacology, ISSN 1567-5769, 11/2019, Volume 76, pp. 105883 - 105883
Myeloperoxidase | Outcome | ANCA-associated vasculitis | Pulse methylprednisolone | Predictors | Pharmacology & Pharmacy | Immunology | Life Sciences & Biomedicine | Science & Technology | Peroxidase - immunology | Kidney - drug effects | Humans | Middle Aged | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - physiopathology | Induction Chemotherapy | Male | Treatment Outcome | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - drug therapy | Antibodies, Antineutrophil Cytoplasmic - immunology |